Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research Report - Global Forecast till 2025

Extracorporeal Membrane Oxygenation Machine Market Research Report: Information by Component (Pumps, Oxygenators, Cannula and others), Modality, Application and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2025

ID: MRFR/HC/6647-HCR | February 2021 | Region: Global | 95 pages

Market Scenario
The global Extracorporeal Membrane Oxygenation Machine Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 with a market value of USD 267.60 million in 2018.
Extracorporeal membrane oxygenation is a machine that provides cardiac and respiratory support for those patients whose heart and lungs are unable to provide an adequate supply of gas exchange to the body. It is also known as a life support machine. People who are suffering from a severe and life-threatening illness needs extracorporeal membrane oxygenation machine to carry out proper functioning of heart and lungs. The global extracorporeal membrane oxygenation machine market is driven by factors such as the growing prevalence of cardiovascular and respiratory diseases, rising adoption of the ECMO machine for lung transplantation, and the growing number of ECMO centers. Additionally, the rising prevalence of lung diseases coupled with increasing geriatric population is anticipated to fuel the market growth. As there is an increasing prevalence of lung and heart diseases, the demand for extracorporeal membrane oxygenation machine is also rising nowadays. As per the survey carried out by World Health Organization in 2017, around 306 hospitals in the US have ECMO machine for treatment of heart and lung diseases that are around 9385 ECMO devices were administered in US hospitals in 2017.  
On the other hand, the complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures are projected to hamper the growth of the market during the assessment period.
Segmentation
The global extracorporeal membrane oxygenation machine market has been segmented based on component, modality, application, and region.
The market, based on component, has been divided into pumps, oxygenators, controllers, cannula,
and accessories. The oxygenators segment is expected to hold a major share in the market due to the rising prevalence of lung diseases and increasing adoption of extracorporeal membrane oxygenation machine for cardiac treatments. The pumps segment is anticipated to be the fastest-growing as these are most widely used in the treatment of asthma.
The market based on modality is further segmented into veno-arterial (VA), veno-venous (VV), and arterio-venous (AV). The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse. Whereas veno-venous segment is expected to be the fastest-growing due to its increasing use in cardiogenic shock.
The market based on application is further segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The extracorporeal membrane oxygenation machine market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European extracorporeal membrane oxygenation machine market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The extracorporeal membrane oxygenation machine market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The extracorporeal membrane oxygenation machine market in the Middle East & Africa has been divided into the Middle East and Africa.
Key Players

 Getinge Group
Medtronic
Livanova PLC
Abbott
Agilent Technologies
Siemens AG
Terumo Corporation
Fresenius Medical Care AG & Co. KGaA
Microport Scientific Corporation
Nipro Corporation
ALung Technologies, Inc.
MAQUET Holding B.V. & Co. KG
Medos Medizintechnik AG
Terumo Cardiovascular Systems Corp
Others

Regional Market Summary
Global Extracorporeal Membrane Oxygenation Machine Market Share, by Region, 2018 (%)
 
Source: World Health Organization (WHO)
The market in the Americas is expected to dominate the global extracorporeal membrane oxygenation machine market due to the rising incidence of lung cancer, favorable reimbursement scenario, and increasing investment in research and development of new medical devices. As there is a rising prevalence of lung cancer in the US, the demand for extracorporeal membrane oxygenation machine is also increasing in this region. As per the survey carried out by the America Lung Association in 2017, around 11 million people are diagnosed with COPD in the US every year. High cases of COPD in the US and Canada is expected to drive the market growth.
The market in Europe showed a substantial amount of growth. This can be attributed to the presence of a well-established healthcare system, an increase in chronic diseases, and the involvement of key companies. As per the Luce Report on Lung Cancer 2016, around 312,000 people in Europe have lung cancer. As there is an increasing prevalence of lung cancer in this region, the demand for extracorporeal membrane oxygenation machine is also growing. Therefore, the market is expected to grow during the forecast period.
The market in Asia-Pacific is projected to be the fastest-growing over the forecast period owing to the rising prevalence of lung cancer in countries such as India and China. According to National Cancer Center (NCC) Report 2018, out of a total population around 35.1%, people are diagnosed with lung cancer every year in China and is one of the leading cause of deaths in this country. 
The market in the Middle East & Africa is projected to account for the least share of the global extracorporeal membrane oxygenation machine market due to low disposable income in the region.
Global Extracorporeal Membrane Oxygenation Machine Market, by Component

Pumps
Oxygenators
Controllers
Cannula
Accessories

Global Extracorporeal Membrane Oxygenation Machine Market, by Modality

Veno-Arterial (VA)
Veno-Venous (VV)
Arterio-Venous (AV)

Global Extracorporeal Membrane Oxygenation Machine Market, by Application

Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Global Extracorporeal Membrane Oxygenation Machine Market, by Region

Americas

North America

US
Canada

Latin America

Europe

Western Europe

Germany
France
Italy
Spain
UK
Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan
China
India
Australia
South Korea
Rest of Asia-Pacific

Middle East & Africa

Middle East
Africa

Intended Audience

Research and development (R&D) companies
Medical device companies
Government research institutes
Academic institutes and universities
Venture capitalists



Frequently Asked Questions (FAQ) :


Extracorporeal Membrane Oxygenation Machine (ECMO) Marketis expected to exhibit a solid 4.8% CAGR over the forecast period from 2019 to 2025.

The increasing prevalence of cardiovascular concerns is the major driver for the global extracorporeal membrane oxygenation machine market.

The Americas market is expected to hold the largest share in the market.

Leading players in the extracorporeal membrane oxygenation machine market include Getinge Group, Agilent, Abbott, and Siemens, among others.

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Extracorporeal Membrane Oxygenation Machine Market, by Component

6.1 Introduction

6.2 Pumps

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3 Oxygenators

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4 Controllers

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.5 Cannula

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.6 Accessories

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025
Chapter 7. Global Extracorporeal Membrane Oxygenation Machine Market, by Modality

7.1 Introduction

7.2 Veno-Arterial (VA)

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.3 Veno-Venous (VV)

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.4 Arterio-Venous (AV)

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

Chapter 8. Global Extracorporeal Membrane Oxygenation Machine Market, by Application

8.1 Introduction

8.2 Respiratory

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.3 Cardiac

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

Chapter 9. Global Extracorporeal Membrane Oxygenation Machine Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Getinge Group

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Medtronic

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Livanova PLC

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Abbott

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Agilent Technologies

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Siemens AG

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Terumo Corporation

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Fresenius Medical Care AG & Co. KGaA

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Microport Scientific Corporation

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Nipro Corporation

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 ALung Technologies, Inc

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 MAQUET Holding B.V. & Co. KG

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Medos Medizintechnik AG

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis
11.14 Terumo Cardiovascular Systems Corp

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Extracorporeal Membrane Oxygenation Machine Market Synopsis, 2019–2025

Table 2 Global Extracorporeal Membrane Oxygenation Machine Market Estimates and Forecast, 2019–2025 (USD Million)

Table 3 Global Extracorporeal Membrane Oxygenation Machine Market, by Region, 2019–2025 (USD Million)

Table 4 Global Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 5 Global Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 6 Global Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019- 2025 (USD Million)

Table 7 North America: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 8 North America: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 9 North America: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 10 US: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 11 US: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 12 US: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 13 Canada: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 14 Canada: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 15 Canada: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 16 Latin America: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 17 Latin America: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 18 Latin America: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 19 Europe: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 20 Europe: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 21 Europe: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 22 Western Europe: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 23 Western Europe: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 24 Western Europe: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 25 Eastern Europe: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 26 Eastern Europe: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 27 Eastern Europe: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 28 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 29 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 30 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)

Table 31 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2019–2025 (USD Million)

Table 32 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2019–2025 (USD Million)

Table 33 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019–2025 (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Extracorporeal Membrane Oxygenation Machine Market

Figure 3 Segmentation Market Dynamics for Global Extracorporeal Membrane Oxygenation Machine Market

Figure 4 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Components, 2018

Figure 5 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Modality, 2018

Figure 6 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Application, 2018

Figure 7 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Region, 2018

Figure 8 North America: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2018

Figure 9 Europe: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2018

Figure 10 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2018

Figure 11 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2018

Figure 12 Global Extracorporeal Membrane Oxygenation Machine Market: Company Share Analysis, 2018 (%)

Figure 13 Getinge Group: Key Financials

Figure 14 Getinge Group: Segmental Revenue

Figure 15 Getinge Group: Geographical Revenue

Figure 16 Medtronic: Key Financials

Figure 17 Medtronic: Segmental Revenue

Figure 18 Medtronic: Geographical Revenue

Figure 19 Livanova PLC: Key Financials

Figure 20 Livanova PLC: Segmental Revenue

Figure 21 Livanova PLC: Geographical Revenue

Figure 22 Abbott: Key Financials

Figure 23 Abbott: Segmental Revenue

Figure 24 Abbott: Geographical Revenue

Figure 25 Agilent Technologies: Key Financials

Figure 26 Agilent Technologies: Segmental Revenue

Figure 27 Agilent Technologies: Geographical Revenue

Figure 28 Siemens AG: Key Financials

Figure 29 Siemens AG: Segmental Revenue

Figure 30 Siemens AG: Geographical Revenue

Figure 31 Terumo Corporation: Key Financials

Figure 32 Terumo Corporation: Segmental Revenue

Figure 33 Terumo Corporation: Geographical Revenue

Figure 34 Fresenius Medical Care AG & Co. KGaA: Key Financials

Figure 35 Fresenius Medical Care AG & Co. KGaA: Segmental Revenue

Figure 36 Fresenius Medical Care AG & Co. KGaA: Geographical Revenue

Figure 37 Microport Scientific Corporation: Key Financials

Figure 38 Microport Scientific Corporation: Segmental Revenue

Figure 39 Microport Scientific Corporation: Geographical Revenue

Figure 40 Nipro Corporation: Key Financials

Figure 41 Nipro Corporation: Segmental Revenue

Figure 42 Nipro Corporation: Geographical Revenue

Figure 43 ALung Technologies, Inc.: Key Financials

Figure 44 ALung Technologies, Inc.: Segmental Revenue

Figure 45 ALung Technologies, Inc.: Geographical Revenue

Figure 46 MAQUET Holding B.V. & Co. KG: Key Financials

Figure 47 MAQUET Holding B.V. & Co. KG: Segmental Revenue

Figure 48 MAQUET Holding B.V. & Co. KG: Geographical Revenue

Figure 49 Medos Medizintechnik AG: Key Financials

Figure 50 Medos Medizintechnik AG: Segmental Revenue

Figure 51 Medos Medizintechnik AG: Geographical Revenue

Figure 52 Terumo Cardiovascular Systems Corp: Key Financials

Figure 53 Terumo Cardiovascular Systems Corp: Segmental Revenue

Figure 54 Terumo Cardiovascular Systems Corp: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.